UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CFI 192/2025

Mar 3, 2025·EP4241767: NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Case details
Status
Interim Phase
Action
Infringement
Category
Main Infringement Action
Parties
Claimants
Reps: Eveline Lots; Hendrik Lambers; Koen Bijvank; Lilia Bouzoraa; Mark van Gardingen
Respondents
Reps: Kilian Seidel
Division
The Hague LD
Judges
Technology
Biotech · mRNA · Biotechnology
Language
English
Documents
Document titleDatePublic
Hearing recording reference document2026-03-09Not public
Receipt2026-03-04Not public
Cover sheet2026-03-04Not public
Application document Claimant2026-03-04Not public
Receipt2026-02-27Not public
Cover sheet2026-02-27Not public
Document Defendant2026-02-27Not public
action.communication.general2026-02-27Not public
Receipt2026-02-26Not public
Cover sheet2026-02-26Not public
Fee2026-02-26Not public
Application document Defendant2026-02-26Not public
action.issueOrder.order2026-02-12Not public
Order2026-02-12Public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Claimant2026-01-21Not public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Defendant2026-01-21Not public
action.phaseChange.interimPhaseOpen2026-01-14Not public
action.phaseChange.writtenPhaseClose2026-01-14Not public
Cover sheet2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Exhibit document Defendant2025-11-10Not public
Statement of rejoinder2025-11-10Not public
Receipt2025-11-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
20250910 - 767 - Reference to SoR and Defence to CC and Application to Amend2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o2025-09-10Not public
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid2025-09-10Not public
Exhibit A105 - US 61-222.469 - FBD-T 65 P12025-09-10Not public
Exhibit A099 - Register extract of FBD-T 662025-09-10Not public
Exhibit A116 - Moderna Biotech Spain documentation of Spikevax supply and invoicing to EU states2025-09-10Not public
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information2025-09-10Not public
Exhibit A102 - US 61-242.761 - FBD-T 63 P32025-09-10Not public
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)2025-09-10Not public
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration2025-09-10Not public
Exhibit A118 - Moderna Italy webpage2025-09-10Not public
Exhibit A101 - US 61-234.045 - FBD-T 63 P22025-09-10Not public
Exhibit A107 - US 61-159.788 - FBD-T 62 P12025-09-10Not public
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain - Moderna Switzerland and Moderna Netherla2025-09-10Not public
Exhibit A108 - US 61-231.579 - FBD-T 62 P22025-09-10Not public
Exhibit A104 - US 61-258.848 - FBD-T 63 P52025-09-10Not public
Exhibit A106 - US 61-222.464 - FBD-T 67 P12025-09-10Not public
Exhibit A103 - US 61-251.999 - FBD-T 63 P42025-09-10Not public
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis2025-09-10Not public
Exhibit A092 - EP 767 Claim requests (tracked changes version)2025-09-10Not public
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids2025-09-10Not public
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery - improved endosomal escape and sustained phar2025-09-10Not public
Reply to SoD + Defence to CC + App to Amend2025-09-10Not public
Exhibit A100 - US 61-175.777 - FBD-T 63 P12025-09-10Not public
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery2025-09-10Not public
Exhibit A094 - Jeffs 2005 - A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA2025-09-10Not public
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery2025-09-10Not public
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio2025-09-10Not public
Exhibit A091 - EP 767 Claim requests (clean version)2025-09-10Not public
Exhibit A115 - Arbutus - Genevant Cross-License Agreement 2018 (SEC version)2025-09-10Not public
Panel-Appointment2025-08-18Not public
Headnote-and-Keywords2025-08-18Not public
Outcome of the Order2025-08-18Not public
Confirmation of PO Order2025-08-18Public
R.37.2 order2025-08-15Public
Joint statement regarding bifurcation2025-08-13Not public
Joint statement regarding bifurcation2025-08-13Not public
Statement regarding security pursuant to R.158 RoP2025-08-11Not public
R.37.22025-08-06Not public
Hearing-Dates2025-08-06Not public
R.282025-08-06Public
Hearing-Dates2025-08-06Not public
opportunity to comment2025-08-04Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Reference to response of Genevant2025-07-28Not public
Acknowledgement-of-lodging2025-07-25Not public
Receipt2025-07-25Not public
Reference to response of Genevant2025-07-23Not public
R.262.2 Application2025-07-23Not public
Exhibit A0882025-07-23Not public
Exhibit A090 - confidential2025-07-23Not public
Confidential Reply Security for Costs2025-07-23Not public
Exhibit A090 - confidential2025-07-23Not public
Confidential Reply Security for Costs2025-07-23Not public
Exhibit A0892025-07-23Not public
Exhibit FBD 052025-07-17Not public
25-06-06_-_EP_254_and_EP_767_-_Request_for_Panel_Review_-_Moderna_vs_Genevant_-_App_No_33094 _20252025-07-17Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
Formal-checks_Notification-of-positive-outcome2025-07-10Not public
opportunity to comment2025-07-09Not public
Template-Order2025-07-09Not public
Receipt2025-07-09Not public
Exhibit FBD 122025-07-09Not public
Exhibit FBD 112025-07-09Not public
25-07-07_-_UPC1_EP767_UPC_DRAFT_-_Request_security_pursuant_to_R158(307434330.1)2025-07-09Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
EP 767 - Moderna Reference to Statement of Defence2025-07-08Not public
Exhibit FBD 42025-07-08Not public
Exhibit FBD-T 462025-07-08Not public
Exhibit FBD-T 662025-07-08Not public
Exhibit FBD-T 582025-07-08Not public
Exhibit FBD-T 42025-07-08Not public
Exhibit FBD-T 212025-07-08Not public
Exhibit FBD 82025-07-08Not public
Exhibit FBD-T 642025-07-08Not public
Exhibit FBD-T 592025-07-08Not public
Exhibit FBD-T 192025-07-08Not public
Exhibit FBD-T 162025-07-08Not public
Exhibit FBD-T 62025-07-08Not public
Exhibit FBD-T 472025-07-08Not public
Exhibit FBD-T 102025-07-08Not public
Exhibit FBD-T 362025-07-08Not public
Exhibit FBD 92025-07-08Not public
Exhibit FBD-T 82025-07-08Not public
Exhibit FBD 112025-07-08Not public
Exhibit FBD-T 232025-07-08Not public
Exhibit FBD-T 442025-07-08Not public
Exhibit FBD-T 682025-07-08Not public
Exhibit FBD-T 482025-07-08Not public
Exhibit FBD-T 92025-07-08Not public
Exhibit FBD-T 272025-07-08Not public
Exhibit FBD 32025-07-08Not public
Exhibit FBD 7 - Part 5 of 52025-07-08Not public
Exhibit FBD 122025-07-08Not public
Exhibit FBD-T 182025-07-08Not public
EP 767 - Moderna Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Exhibit FBD-T 252025-07-08Not public
Exhibit FBD-T 322025-07-08Not public
Exhibit FBD-T 312025-07-08Not public
Exhibit FBD-T 372025-07-08Not public
Exhibit FBD-T 632025-07-08Not public
Exhibit FBD-T 12025-07-08Not public
Exhibit FBD-T 262025-07-08Not public
Exhibit FBD-T 222025-07-08Not public
Exhibit FBD 7 - Part 2 of 52025-07-08Not public
Exhibit FBD-T 602025-07-08Not public
Exhibit FBD-T 32025-07-08Not public
Exhibit FBD-T 302025-07-08Not public
Exhibit FBD-T 562025-07-08Not public
Exhibit FBD-T 342025-07-08Not public
Exhibit FBD-T 292025-07-08Not public
Exhibit FBD-T 332025-07-08Not public
Exhibit FBD-T 612025-07-08Not public
Exhibit FBD-T 112025-07-08Not public
Exhibit FBD-T 672025-07-08Not public
Exhibit FBD 7 - Part 3 of 52025-07-08Not public
Exhibit FBD-T 652025-07-08Not public
Exhibit FBD-T 432025-07-08Not public
Exhibit FBD-T 692025-07-08Not public
Exhibit FBD-T 542025-07-08Not public
Exhibit FBD-T 242025-07-08Not public
Exhibit FBD-T 402025-07-08Not public
Exhibit FBD-T 502025-07-08Not public
Exhibit FBD 62025-07-08Not public
Exhibit FBD-T 282025-07-08Not public
Exhibit FBD-T 72025-07-08Not public
Exhibit FBD-T 352025-07-08Not public
Exhibit FBD 7 - Part 1 of 52025-07-08Not public
Exhibit FBD-T 492025-07-08Not public
Exhibit FBD-T 412025-07-08Not public
Exhibit FBD-T 132025-07-08Not public
Exhibit FBD-T 702025-07-08Not public
Exhibit FBD-T 532025-07-08Not public
Exhibit FBD-T 172025-07-08Not public
Exhibit FBD-T 572025-07-08Not public
Exhibit FBD-T 382025-07-08Not public
Exhibit FBD-T 552025-07-08Not public
Exhibit FBD-T 512025-07-08Not public
Exhibit FBD-T 202025-07-08Not public
Exhibit FBD 7 - Part 4 of 52025-07-08Not public
Exhibit FBD-T 142025-07-08Not public
Exhibit FBD-T 452025-07-08Not public
Exhibit FBD 102025-07-08Not public
Exhibit FBD-T 52025-07-08Not public
Exhibit FBD-T 152025-07-08Not public
Exhibit FBD-T 22025-07-08Not public
Exhibit FBD 52025-07-08Not public
Exhibit FBD-T 622025-07-08Not public
Exhibit FBD-T 422025-07-08Not public
Exhibit FBD-T 522025-07-08Not public
Exhibit FBD-T 392025-07-08Not public
Exhibit FBD-T 122025-07-08Not public
Outcome of the Order2025-06-04Not public
rectification2025-06-04Public
Response to request for rectification2025-06-02Not public
Response to request for rectification2025-06-02Not public
opportunity to comment2025-05-28Not public
Receipt2025-05-27Not public
25-05-27_-_Request_for_Rectification_-_Moderna_vs_Genevant_-_CFI_191_2025_and_CFI_192_20252025-05-27Not public
Preliminary_Objection_DecisionOutcome2025-05-23Not public
R.19 order2025-05-23Public
Preliminary_Objection_DecisionOutcome2025-05-23Not public
R.19 order2025-05-23Public
Comment-On-Preliminary-Objection2025-05-08Not public
Comment on Preliminary objection2025-05-08Not public
Exhibit A087 - Notice 2025 European tender2025-05-08Not public
Comment-On-Preliminary-Objection2025-05-07Not public
Exhibit A087 - Notice 2025 European tender2025-05-07Not public
Comment on Preliminary objection2025-05-07Not public
Notification Of Service2025-05-06Not public
2025_05_05 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Norway AS2025-05-06Not public
Acknowledgement of access to case2025-05-05Not public
Acknowledgement of access to case2025-05-05Not public
Acknowledgement of access to case2025-05-05Not public
Notification Of Service2025-05-01Not public
2025-04-29 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of service Sweden2025-05-01Not public
Notification Of Service2025-05-01Not public
2025_03_24 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Switzerland GmbH2025-05-01Not public
Preliminary-Objection2025-04-25Not public
Notification Of Service2025-04-25Not public
2025_23_04 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Inc.2025-04-25Not public
Preliminary Objections of Defendants 1-142025-04-24Not public
Exhibit FBD 22025-04-24Not public
Acknowledgement of access to case2025-04-24Not public
Preliminary-Objection2025-04-23Not public
Preliminary objection on behalf of Moderna UK2025-04-22Not public
Notification Of Service2025-04-22Not public
2025_04_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service ModernaTX Inc2025-04-22Not public
Headnote-and-Keywords2025-04-17Not public
this order is issued in this workflow for technical reasons only2025-04-17Public
Outcome of the Order2025-04-17Not public
this order is issued in this workflow for technical reasons only2025-04-17Public
Outcome of the Order2025-04-17Not public
Receipt2025-04-17Not public
setting deadline for SoD2025-04-17Public
Template-Order2025-04-17Not public
Further response re deadline extension2025-04-17Not public
Receipt2025-04-17Not public
R9 Request re service Moderna Inc and ModernaTX Inc2025-04-17Not public
Exhibit A086 - Letter re representation MLL of Moderna Inc ModernaTX Inc2025-04-17Not public
Receipt2025-04-15Not public
Response re request for deadline extension2025-04-15Not public
Receipt2025-04-14Not public
R 9 aplication reply to R 9 request2025-04-14Not public
opportunity to comment2025-04-10Not public
Template-Order2025-04-10Not public
opportunity to comment2025-04-09Not public
Receipt2025-04-09Not public
Request for deadline extension2025-04-09Not public
Exhibit FBD 12025-04-09Not public
Acknowledgement of access to case2025-04-08Not public
Acknowledgement of access to case2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Belgium S.R.L.2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_25 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna France SASU2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_27 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Italy S.R.L.2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Germany GmbH2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_28 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Netherlands B.V.2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_21 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Biotech UK Limited2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_27 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Portugal Unipessoal LDA2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_26 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Denmark ApS2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_26 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Biotech Spain SL2025-04-08Not public
Notification Of Service2025-04-08Not public
2025_03_25 ACT_10284_2025 UPC_CFI_192_2025 Confirmation of Service Moderna Poland SP. Z.O.O.2025-04-08Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-31Not public
Acknowledgement of access to case2025-03-28Not public
Acknowledgement of access to case2025-03-24Not public
Panel-Appointment2025-03-17Not public
communicationCheck2025-03-17Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Letter-for-Service2025-03-13Not public
Document from EPO2025-03-11Not public
communicationCheck2025-03-11Not public
Document from EPO2025-03-11Not public
communicationCheck2025-03-11Not public
Document from EPO2025-03-11Not public
Panel-Appointment2025-03-06Not public
EPO-Request-for-case-pending2025-03-06Not public
Receipt2025-03-06Not public
Formal-checks_Notification-of-positive-outcome2025-03-06Not public
Exhibit A054 - EC Draft framework contract2025-03-05Not public
Exhibit A046 - Modernatx website2025-03-05Not public
Exhibit A077 - Moderna CH service agreement TR2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A069 - Moderna France trade register2025-03-05Not public
Exhibit A049.04 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A034 - EP 4241767 A22025-03-05Not public
Exhibit A070 - Moderna Italy trade register2025-03-05Not public
Exhibit A039 - Modernas RD Day Presentation 17 September 20202025-03-05Not public
Exhibit A032 - Intention to grant of 28 August 20242025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A007 - Zimmerman 20062025-03-05Not public
Exhibit A049.03 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A017 - Certificate of change of name Tekmira to Arbutus2025-03-05Not public
Exhibit A004 - Proof of payment NL77INGB0675829062_28-02-2025_28-02-20252025-03-05Not public
Exhibit A026 - Transmission of certificate of 18 November 20242025-03-05Not public
Exhibit A052 - Moderna press release 2025 tender2025-03-05Not public
Exhibit A053 - Moderna Inc. press release Chantal-Friebertshauser 20222025-03-05Not public
Exhibit A031 - Letter amendments before examination of 2 April 20242025-03-05Not public
Exhibit A050 - EX - PA EC Moderna CH 20212025-03-05Not public
Exhibit A001 - National register excerpts2025-03-05Not public
Exhibit A063 - Moderna ES trade register2025-03-05Not public
Exhibit A033 - Decision to grant of 29 September 20242025-03-05Not public
Exhibit A049.06 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A072 - Moderna Denmark trade register2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A055 - Moderna NL Trade Register2025-03-05Not public
Exhibit A045 - Domain registrations Moderna2025-03-05Not public
Exhibit A015.04 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A015.02 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A047 - Modernacovid19global website2025-03-05Not public
Exhibit A019 - US20090154350P of 20 February 20092025-03-05Not public
Exhibit A015.03 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A030 - Amended claims of 2 April 20242025-03-05Not public
Exhibit A069 - Moderna France trade register2025-03-05Not public
Exhibit A015.01 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A049.08 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A081 - Moderna ROVI 2022 press release2025-03-05Not public
Exhibit A015.09 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A065 - Moderna Poland trade register2025-03-05Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-05Not public
Exhibit A066 - Moderna UK trade register2025-03-05Not public
Exhibit A049.02 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A003 - EP 4 241 767 B12025-03-05Not public
Exhibit A078 - Moderna press release Lonza NL 20212025-03-05Not public
Exhibit A024 - Request for unitary effect of 31 October 20242025-03-05Not public
Exhibit A014 - Samaridou 20202025-03-05Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-05Not public
Exhibit A071 - Moderna Belgium trade register2025-03-05Not public
Exhibit A079 - Lonza press release 20212025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A036 - Moderna press release 23 August 20242025-03-05Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-05Not public
Exhibit A073 - Moderna Sweden trade register2025-03-05Not public
Exhibit A008 - Press release Tekmira and Alnylam Settlement2025-03-05Not public
Exhibit A038 - Transcript Moderna Vaccines Day 14 April 2021 selection2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A067 - Moderna UK Annual report 20232025-03-05Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-05Not public
Exhibit A085 - Moderna Inc 2024 annual report p. 1152025-03-05Not public
Exhibit A023 - US20090234098P of 14 August 20092025-03-05Not public
Exhibit A061 - Spikevax Lauer Taxe Germany2025-03-05Not public
Exhibit A022 - US20090225898P of 15 July 20092025-03-05Not public
Exhibit A025 - Registration of unitary effect of 13 November 20242025-03-05Not public
Exhibit A016 - Assignment from Alnylam to Tekmira2025-03-05Not public
Statement of Claim EP 767_signed2025-03-05Not public
Exhibit A062 - mRESVIA Lauer Taxe Germany2025-03-05Not public
Exhibit A002 - Confirmatory declaration Genevant-Arbutus2025-03-05Not public
Exhibit A056 - Moderna NL Annual Report 20232025-03-05Not public
Exhibit A027 - Request for application and claims of 24 May 20232025-03-05Not public
Exhibit A005B - Arbutus Biopharma Corporation trade register excerpt2025-03-05Not public
Exhibit A082 - Moderna RECIPHARM 2020 press release2025-03-05Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-05Not public
Exhibit A018 - US20080113179P of 10 November 20082025-03-05Not public
Exhibit A049.01 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A063 - Moderna ES trade register2025-03-05Not public
Exhibit A084 - Moderna 2023 annual report p. 1192025-03-05Not public
Exhibit A012 - Cross CEN News 20212025-03-05Not public
Exhibit A068 - Moderna Germany trade register2025-03-05Not public
Exhibit A074 - Moderna Norway trade register2025-03-05Not public
Exhibit A040 - Modernas RD Day Transcript 17 September 2020 selection2025-03-05Not public
Exhibit A010 - Corbett Nature Review 20202025-03-05Not public
Exhibit A035 - mRESVIA SmPC2025-03-05Not public
Exhibit A073 - Moderna Sweden trade register2025-03-05Not public
Exhibit A083 - Moderna RECIPHARM 2021 press release2025-03-05Not public
Exhibit A075 - Moderna Portugal trade register2025-03-05Not public
Exhibit A011 - Regalado MIT Technology 20202025-03-05Not public
Exhibit A021 - US20090185438P of 9 June 20092025-03-05Not public
Exhibit A028 - European search opinion of 5 October 20232025-03-05Not public
Exhibit A049.05 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A009 - Shaun Ryan (Moderna) Declaration2025-03-05Not public
Exhibit A041 - Moderna Inc trade register excerpt2025-03-05Not public
Exhibit A065 - Moderna Poland trade register2025-03-05Not public
Exhibit A015.07 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A051 - EC press release 2025 tender2025-03-05Not public
Exhibit A072 - Moderna Denmark trade register2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A015.05 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A015.10 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A058 - Moderna NL Hungary contract 20242025-03-05Not public
Exhibit A043 - Moderna Inc 2022 press release2025-03-05Not public
Exhibit A055 - Moderna NL Trade Register2025-03-05Not public
Exhibit A029 - D2 - US6320017B12025-03-05Not public
Exhibit A015.06 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A076 - Moderna Lonza press release 20202025-03-05Not public
Exhibit A037 - EMA assesment report mRESVIA2025-03-05Not public
Exhibit A015.08 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A013 - Clancy S and Brown W (2008) Translation DNA to mRNA to Protein2025-03-05Not public
Statement of Claim EP 767 da2025-03-05Not public
Exhibit A006 - Spikevax SmPC2025-03-05Not public
Exhibit A015.11 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A080 - Moderna ROVI 2020 press release2025-03-05Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-05Not public
Exhibit A068 - Moderna Germany trade register2025-03-05Not public
Exhibit A015.13 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A015.12 - PCT_US2009_063927 of 10 November 20092025-03-05Not public
Exhibit A048 - Moderna Switzerland trade register2025-03-05Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-05Not public
Exhibit A042 - Moderna Inc 2023 annual report exhibit 21 12025-03-05Not public
Exhibit A005A - Genevant Sciences trade register2025-03-05Not public
Exhibit A074 - Moderna Norway trade register2025-03-05Not public
Exhibit A075 - Moderna Portugal trade register2025-03-05Not public
Exhibit A049.07 - APA EC Moderna CH 20202025-03-05Not public
Exhibit A020 - US20090171439P of 21 April 20092025-03-05Not public
Exhibit A044 - ModernaTX trade register excerpt2025-03-05Not public
Formal-checks_Request-for-correction2025-03-04Not public
Acknowledgement-of-lodging2025-03-03Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-03Not public
Exhibit A015.05 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A056 - Moderna NL Annual Report 20232025-03-03Not public
Exhibit A049.07 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A081 - Moderna ROVI 2022 press release2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-03Not public
Exhibit A067 - Moderna UK Annual report 20232025-03-03Not public
Exhibit A079 - Lonza press release 20212025-03-03Not public
Exhibit A007 - Zimmerman 20062025-03-03Not public
Exhibit A028 - European search opinion of 5 October 20232025-03-03Not public
Exhibit A060 - Moderna NL tender notice Poland PL2025-03-03Not public
Exhibit A049.02 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-03Not public
Exhibit A015.12 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A015.03 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A046 - Modernatx website2025-03-03Not public
Exhibit A061 - Spikevax Lauer Taxe Germany2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A074 - Moderna Norway trade register2025-03-03Not public
Exhibit A076 - Moderna Lonza press release 20202025-03-03Not public
Exhibit A069 - Moderna France trade register2025-03-03Not public
Exhibit A040 - Modernas RD Day Transcript 17 September 2020 selection2025-03-03Not public
20250303 Statement of Claim EP 767_signed2025-03-03Not public
Exhibit A008 - Press release Tekmira and Alnylam Settlement2025-03-03Not public
Exhibit A004 - Proof of payment NL77INGB0675829062_28-02-2025_28-02-20252025-03-03Not public
Exhibit A084 - Moderna 2023 annual report p. 1192025-03-03Not public
Exhibit A012 - Cross CEN News 20212025-03-03Not public
Exhibit A052 - Moderna press release 2025 tender2025-03-03Not public
Exhibit A015.06 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A043 - Moderna Inc 2022 press release2025-03-03Not public
Exhibit A039 - Modernas RD Day Presentation 17 September 20202025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A063 - Moderna ES trade register2025-03-03Not public
Exhibit A015.10 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A072 - Moderna Denmark trade register2025-03-03Not public
Exhibit A049.08 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A027 - Request for application and claims of 24 May 20232025-03-03Not public
Exhibit A015.01 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A005A - Genevant Sciences trade register2025-03-03Not public
Exhibit A023 - US20090234098P of 14 August 20092025-03-03Not public
Exhibit A075 - Moderna Portugal trade register2025-03-03Not public
Exhibit A065 - Moderna Poland trade register2025-03-03Not public
Exhibit A049.05 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A030 - Amended claims of 2 April 20242025-03-03Not public
Exhibit A047 - Modernacovid19global website2025-03-03Not public
Exhibit A013 - Clancy S and Brown W (2008) Translation DNA to mRNA to Protein2025-03-03Not public
Exhibit A062 - mRESVIA Lauer Taxe Germany2025-03-03Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A001 - National register excerpts2025-03-03Not public
Exhibit A018 - US20080113179P of 10 November 20082025-03-03Not public
Exhibit A016 - Assignment from Alnylam to Tekmira2025-03-03Not public
Exhibit A015.08 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A068 - Moderna Germany trade register2025-03-03Not public
Exhibit A025 - Registration of unitary effect of 13 November 20242025-03-03Not public
Exhibit A015.09 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A073 - Moderna Sweden trade register2025-03-03Not public
Exhibit A015.11 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A032 - Intention to grant of 28 August 20242025-03-03Not public
Exhibit A049.04 - APA EC Moderna CH 20202025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A015.13 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A006 - Spikevax SmPC2025-03-03Not public
Exhibit A042 - Moderna Inc 2023 annual report exhibit 21 12025-03-03Not public
Exhibit A033 - Decision to grant of 29 September 20242025-03-03Not public
Exhibit A078 - Moderna press release Lonza NL 20212025-03-03Not public
Exhibit A021 - US20090185438P of 9 June 20092025-03-03Not public
Exhibit A057 - Moderna NL Hungary contract 2023 HUN2025-03-03Not public
Exhibit A083 - Moderna RECIPHARM 2021 press release2025-03-03Not public
Exhibit A009 - Shaun Ryan (Moderna) Declaration2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A055 - Moderna NL Trade Register2025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A063 - Moderna ES trade register2025-03-03Not public
Exhibit A014 - Samaridou 20202025-03-03Not public
Exhibit A077 - Moderna CH service agreement TR2025-03-03Not public
Exhibit A070 - Moderna Italy trade register2025-03-03Not public
Exhibit A022 - US20090225898P of 15 July 20092025-03-03Not public
Exhibit A059 - Moderna NL PL tender notice PL2025-03-03Not public
Exhibit A044 - ModernaTX trade register excerpt2025-03-03Not public
Exhibit A015.07 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A019 - US20090154350P of 20 February 20092025-03-03Not public
Exhibit A015.02 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A054 - EC Draft framework contract2025-03-03Not public
Exhibit A069 - Moderna France trade register2025-03-03Not public
Exhibit A005B - Arbutus Biopharma Corporation trade register excerpt2025-03-03Not public
Exhibit A064 - Moderna Netherlands Madrid2025-03-03Not public
Exhibit A037 - EMA assesment report mRESVIA2025-03-03Not public
Exhibit A026 - Transmission of certificate of 18 November 20242025-03-03Not public
Exhibit A073 - Moderna Sweden trade register2025-03-03Not public
Exhibit A031 - Letter amendments before examination of 2 April 20242025-03-03Not public
Exhibit A055 - Moderna NL Trade Register2025-03-03Not public
Exhibit A051 - EC press release 2025 tender2025-03-03Not public
Exhibit A050 - EX - PA EC Moderna CH 20212025-03-03Not public
Exhibit A065 - Moderna Poland trade register2025-03-03Not public
Exhibit A048 - Moderna Switzerland trade register2025-03-03Not public
Exhibit A049.03 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A015.04 - PCT_US2009_063927 of 10 November 20092025-03-03Not public
Exhibit A053 - Moderna Inc. press release Chantal-Friebertshauser 20222025-03-03Not public
Exhibit A010 - Corbett Nature Review 20202025-03-03Not public
Exhibit A080 - Moderna ROVI 2020 press release2025-03-03Not public
Exhibit A038 - Transcript Moderna Vaccines Day 14 April 2021 selection2025-03-03Not public
Exhibit A066 - Moderna UK trade register2025-03-03Not public
Exhibit A029 - D2 - US6320017B12025-03-03Not public
Exhibit A041 - Moderna Inc trade register excerpt2025-03-03Not public
Exhibit A049.01 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A082 - Moderna RECIPHARM 2020 press release2025-03-03Not public
Exhibit A068 - Moderna Germany trade register2025-03-03Not public
Exhibit A075 - Moderna Portugal trade register2025-03-03Not public
Exhibit A003 - EP 4 241 767 B12025-03-03Not public
Exhibit A071 - Moderna Belgium trade register2025-03-03Not public
Exhibit A049.06 - APA EC Moderna CH 20202025-03-03Not public
Exhibit A036 - Moderna press release 23 August 20242025-03-03Not public
Exhibit A017 - Certificate of change of name Tekmira to Arbutus2025-03-03Not public
Exhibit A085 - Moderna Inc 2024 annual report p. 1152025-03-03Not public
Exhibit A045 - Domain registrations Moderna2025-03-03Not public
Exhibit A002 - Confirmatory declaration Genevant-Arbutus2025-03-03Not public
Exhibit A074 - Moderna Norway trade register2025-03-03Not public
Exhibit A011 - Regalado MIT Technology 20202025-03-03Not public
20250303 SoC EP 767 DA2025-03-03Not public
Exhibit A020 - US20090171439P of 21 April 20092025-03-03Not public
Exhibit A072 - Moderna Denmark trade register2025-03-03Not public
Exhibit A058 - Moderna NL Hungary contract 20242025-03-03Not public
Exhibit A024 - Request for unitary effect of 31 October 20242025-03-03Not public
Exhibit A034 - EP 4241767 A22025-03-03Not public